Corvus Pharmaceuticals(DE:C17)
€10.13-0.07 (-0.74%)
DE:C17
Corvus Pharmaceuticals earnings date
€10.13
At close:-0.07 (-0.74%)
Corvus Pharmaceuticals (C17) Q2 2022 Earnings Report
0 Followers
DE:C17 Q2 2022 EPS Results
- Actual EPS
- -EUR 0.16
- Consensus EPS
- -EUR 0.16
- Beat/Miss
- Missed by -EUR 0.00
- One Year Ago EPS
- -EUR 0.25
DE:C17 Q2 2022 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/08/2022
- Time
- After Close
- Conference Call
- Monday, August 8, 2022
DE:C17 Upcoming Earnings
Corvus Pharmaceuticals's next earnings date is estimated for March 24, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:C17 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 24, 2027 | 2026 (Q4) | -0.20- | -0.13 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.17-0.20 | -0.11 | -83.33% (-0.09) | |
| Aug 06, 2026 | 2026 (Q2) | -0.14-0.17 | -0.09 | -90.00% (-0.08) | |
| May 07, 2026 | 2026 (Q1) | -0.13-0.13 | -0.12 | -15.38% (-0.02) | |
| Mar 12, 2026 | 2025 (Q4) | -0.12-0.13 | -0.16 | 16.67% (+0.03) | |
| Nov 04, 2025 | 2025 (Q3) | -0.11-0.11 | -0.54 | 80.00% (+0.43) | |
| Aug 07, 2025 | 2025 (Q2) | -0.12-0.09 | -0.06 | -42.86% (-0.03) | |
| May 08, 2025 | 2025 (Q1) | -0.11-0.12 | -0.11 | -8.33% (-0.01) | |
| Mar 25, 2025 | 2024 (Q4) | -0.10-0.16 | -0.13 | -28.57% (-0.04) | |
| Nov 12, 2024 | 2024 (Q3) | -0.10-0.54 | -0.11 | -400.00% (-0.43) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
